NCT02199002

Brief Summary

Gastroesophageal reflux disease (GERD) is a very common condition affecting up to 30% of adults. To date, therapy consists of powerful acid suppression with proton pump inhibitors (PPI). Nevertheless, only 60-70% of GERD patients report complete symptom relief with this therapy. As the mechanisms underlying symptom perception in PPI resistant patients are not fully understood, there is currently no adequate therapy available. It is becoming increasingly clear that reflux, especially in the postprandial period, occurs from a reservoir of acid floating on top of the meal: the so-called "acid pocket". In this study, we aim to investigate further the acid pocket by determining its exact position and chemical contents between healthy volunteers, GERD patient who respond well and bad to PPI therapy and GERD patients with barrett's esophagus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

July 17, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 24, 2014

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
Last Updated

February 10, 2023

Status Verified

February 1, 2023

Enrollment Period

3.5 years

First QC Date

July 17, 2014

Last Update Submit

February 7, 2023

Conditions

Keywords

acid pocketGERDBarrett

Outcome Measures

Primary Outcomes (1)

  • acid pocket position

    Acid position will be determined relatively to the lower esophageal sfincter. Differences in position between healthy volunteers, PPI responders, PPI non-responders and patients with barrett esophagus will be evaluated

    participants will be followed for 24 hours

Secondary Outcomes (1)

  • number of reflux episodes

    24 hours

Other Outcomes (1)

  • acid pocket contents

    1 year

Study Arms (5)

healthy volunteers

OTHER

healthy volunteers (no gastric complains)

Device: multi-pH-impedance manometry catheter

PPI responders

OTHER

proven reflux, good symptom relief upon PPI therapy

Device: multi-pH-impedance manometry catheter

PPI non-responders

OTHER

proven reflux disease, poor symptom control (less then 50% symptom reduction) upon PPI therapy (2x40mg omeprazole)

Device: multi-pH-impedance manometry catheter

Barrett - no dysplasia

OTHER

proven barrett with no dysplasia on biopsies

Device: multi-pH-impedance manometry catheter

barrett - high grade dysplasia

OTHER

proven barrett with high grade dysplasia on biopsies

Device: multi-pH-impedance manometry catheter

Interventions

a special catheter will be placed in the esophagus of all study groups. Measurment of pH, impedance and pressure will be performed.

Barrett - no dysplasiaPPI non-respondersPPI respondersbarrett - high grade dysplasiahealthy volunteers

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • signed informed consent
  • older than 18 years
  • fit to criteria of 'study population' (HV, PPI responder, PPI non-responder, Barrett)

You may not qualify if:

  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catholic University Leuven

Leuven, 3000, Belgium

Location

MeSH Terms

Conditions

Barrett EsophagusGastroesophageal Reflux

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesEsophageal Motility DisordersDeglutition Disorders

Study Officials

  • Guy Boeckxstaens, MD, PhD

    Catholic University Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

July 17, 2014

First Posted

July 24, 2014

Study Start

July 1, 2014

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

February 10, 2023

Record last verified: 2023-02

Locations